Morgans Hotel Group Co. (MHGC) is Trading Higher on Unusual Volume for December 21

Equities Staff |

Morgans Hotel Group Co. (MHGC) experienced unusually high volume on Dec. 21, as the stock gained 5.43% to a closing price of $3.30. The stock saw 318,629 shares trade hands over the course of the day on 1,226 trades. Given that the stock’s average daily volume over the last month has been 136,364 shares a day, this represents a pretty substantial spike over the norm.

Morgans Hotel Group Co. has a P/B ratio of -0.35. The stock has traded between $8.00 and $2.93 over the last 52-weeks, its 50-day SMA is now $3.40, and its 200-day SMA $5.42.

Morgans Hotel Group Co, operates, owns, acquires, develops and redevelops boutique hotels, in gateway cities and select resort markets in the United States, Europe and other international locations.

Headquartered in New York, NY, Morgans Hotel Group Co. has 2,600 employees and is currently under the leadership of CEO Richard Szymanski.

For a complete fundamental analysis analysis of Morgans Hotel Group Co., check out’s Stock Valuation Analysis report for MHGC. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Dropbox, Inc.

Dropbox is a service that allows their users to bring all photos, docs, and videos anywhere, and share them easily. Any file saved to Dropbox will automatically save to all…


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.